Esculentoside A inhibits LPS-induced acute kidney injury by activating PPAR-γ

被引:29
|
作者
Chen, De-zhun
Chen, Li-qiong
Lin, Meng-xiang
Gong, Yu-qiang
Ying, Bin-yu
Wei, Da-zhen [1 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 2, Dept Anesthesiol Crit Care & Pain Med, Wenzhou 325000, Zhejiang, Peoples R China
关键词
Acute kidney injury; Esculentoside A; LPS; NF-kappa B; PPAR-gamma; NF-KAPPA-B; RENAL ISCHEMIA/REPERFUSION INJURY; HOSPITALIZED-PATIENTS; SIGNALING PATHWAY; IN-VIVO; AGONIST; SEPSIS; MORTALITY; RATS; MICE;
D O I
10.1016/j.micpath.2017.06.037
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Acute kidney injury (AKI) is a major clinical problem associated with high morbidity and mortality. Esculentoside A (EsA), a kind of saponin isolated from the root of the Chinese herb Phytolaca esculenta, has been reported to have anti-inflammatory effect. In this study, we aimed to investigate the protective effects of EsA on LPS-induced AKI in mice. The protective effects of EsA was evaluated by detecting kidney histological change, blood urea nitrogen (BUN) and creatinine levels, and inflammatory cytokines production. The results showed that EsA significantly attenuated LPS-induced kidney histological change, as well as BUN and creatinine levels. EsA also inhibited LPS-induced TNF-alpha, IL-beta,and IL-6 production. LPS-induced NF-kappa B activation was significantly suppressed by treatment of EsA. In addition, EsA up regulated the expression of PPAR-gamma in a dose-dependent manner. In conclusion, EsA protected mice effectively from LPS-induced AKI by PPAR-y, which subsequently inhibited LPS-induced inflammatory response. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:208 / 213
页数:6
相关论文
共 50 条
  • [1] Esculentoside A inhibits LPS-induced BV2 microglia activation through activating PPAR-γ
    Dong Li-hua
    Li Yan
    Wang Shi-ji
    Wang Guang
    Sheng Lu-lu
    Pan Xue-feng
    Sun Pengda
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 813 : 61 - 65
  • [2] Protective Effects of Isoliquiritigenin on LPS-Induced Acute Lung Injury by Activating PPAR-γ
    Zhang, Wenbin
    Wang, Gui
    Zhou, Shujun
    INFLAMMATION, 2018, 41 (04) : 1290 - 1296
  • [3] Protective Effects of Isoliquiritigenin on LPS-Induced Acute Lung Injury by Activating PPAR-γ
    Wenbin Zhang
    Gui Wang
    Shujun Zhou
    Inflammation, 2018, 41 : 1290 - 1296
  • [4] Effects of alliin on LPS-induced acute lung injury by activating PPARγ
    Wang, Yi-luan
    Guo, Xian-yang
    He, Wei
    Chen, Ru-jie
    Zhuang, Rong
    MICROBIAL PATHOGENESIS, 2017, 110 : 375 - 379
  • [5] The Protective Effects of Terpinen-4-ol on LPS-Induced Acute Lung Injury via Activating PPAR-γ
    Ning, Jun
    Xu, Li
    Zhao, Qing
    Zhang, Yu-yan
    Shen, Chang-qing
    INFLAMMATION, 2018, 41 (06) : 2012 - 2017
  • [6] The Protective Effects of Terpinen-4-ol on LPS-Induced Acute Lung Injury via Activating PPAR-γ
    Jun Ning
    Li Xu
    Qing Zhao
    Yu-yan Zhang
    Chang-qing Shen
    Inflammation, 2018, 41 : 2012 - 2017
  • [7] Asperosaponin VI inhibits LPS-induced inflammatory response by activating PPAR-γ pathway in primary microglia
    Zhang, Jinqiang
    Yi, Saini
    Xiao, Chenghong
    Li, Yahui
    Liu, Chan
    Jiang, Weike
    Yang, Changgui
    Zhou, Tao
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2020, 27 (11) : 3138 - 3144
  • [8] Emodin inhibits LPS-induced inflammatory response by activating PPAR-γ in mouse mammary epithelial cells
    Yang, Zhengtao
    Zhou, Ershun
    Wei, Dong
    Li, Depeng
    Wei, Zhengkai
    Zhang, Wen
    Zhang, Xicheu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 21 (02) : 354 - 360
  • [9] Nuciferine inhibits LPS-induced inflammatory response in BV2 cells by activating PPAR-γ
    Zhang, Lina
    Gao, Jinghua
    Tang, Peng
    Chong, Li
    Liu, Yue
    Liu, Peng
    Zhang, Xin
    Chen, Li
    Hou, Chen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 63 : 9 - 13
  • [10] Citral inhibits lipopolysaccharide-induced acute lung injury by activating PPAR-γ
    Shen, Yongbin
    Sun, Zhanfeng
    Guo, Xiaotong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 747 : 45 - 51